@Pharmafocus

Pharmafocus Magazine - covering pharma and biotech since 1986.

pharmafocus.com
Joined December 2008
  • Tweets27.4K
  • Following1.7K
  • Followers48.2K
7.4KMedia
Acumentis CEO Herspiegel steps down as Burden assumes role pharmafile.com/appointments/…

Acumentis CEO Herspiegel steps down as Burden assumes role - Pharmafile

Ramil Burden is the new Chief Executive Officer of Acumetis, announced the company in a recent statement. 

pharmafile.com
271
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia pharmafile.com/news/sobis-ol…

Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia - Pharmafile

Sobi’s olezarsen (TRYNGOLZA) has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP),

pharmafile.com
280
Hot-tub therapy tested as potential treatment for peripheral artery disease pharmafile.com/news/hot-tub-…

Hot-tub therapy tested as potential treatment for peripheral artery disease - Pharmafile

Researchers at Manchester Metropolitan University are investigating whether regular hot-water immersion can improve mobility and relieve pain in people with

pharmafile.com
264
Raimond takes helm at Nuclera pharmafile.com/appointments/…

Raimond takes helm at Nuclera - Pharmafile

Nuclera, the biotechnology company enabling access to innovative protein technologies, has appointed Carl Raimond as Chief Executive Officer, effective

pharmafile.com
386
Most advanced breast cancer patients treated in community settings, Phesi study finds pharmafile.com/news/most-adv…

Most advanced breast cancer patients treated in community settings, Phesi study finds - Pharmafile

Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community settings rather than academic centres,

pharmafile.com
316
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison pharmafile.com/news/orforgli…

Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison -...

Pharmaceutical firm Lilly’s orforglipron was associated with greater reductions in body weight and blood glucose than oral semaglutide in adults with type 2

pharmafile.com
1
1
1
400
The extended deadline for the EHP Awards 2027 is here! If you are finalising your submission or interested in entering but concerned about meeting the deadline, please contact [email protected] for assistance. Enter here: ehpawards.com/how-to-enter #EHPAwards
268
Bramacare opens supported-living facility for eating disorder recovery pharmafile.com/news/bramacar…

Bramacare opens supported-living facility for eating disorder recovery - Pharmafile

Bramacare has opened a new facility in Ipswich offering supported living for adults recovering from complex eating disorders, providing a transitional stage

pharmafile.com
281
Aiforia deal to expand access to pathology AI pharmafile.com/news/aiforia-…

Aiforia deal to expand access to pathology AI - Pharmafile

Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital pathology available to laboratories

pharmafile.com
482
SMC accepts atogepant for acute migraine treatment in Scotland pharmafile.com/news/smc-acce…

SMC accepts atogepant for acute migraine treatment in Scotland - Pharmafile

The Scottish Medicines Consortium (SMC) has accepted AbbVie’s Aquipta (atogepant) as an option for the acute treatment of migraine with or without aura in

pharmafile.com
1
484
New CCO Ogburn joins Cori Clinical pharmafile.com/appointments/…

New CCO Ogburn joins Cori Clinical - Pharmafile

Cori Clinical has announced the appointment of Dr Emma Ogburn as Chief Clinical Officer. She joins Cori’s founding team of industry veterans, including CEO

pharmafile.com
421
Claris reports visual acuity gains with experimental LSCD treatment pharmafile.com/news/claris-r…

Claris reports visual acuity gains with experimental LSCD treatment - Pharmafile

Claris Biotherapeutics has reported visual acuity improvements with its experimental therapy CSB-001 in a proof-of-concept study involving patients with

pharmafile.com
1
317
Amphista doses first patient in AML trial of protein degrader pharmafile.com/news/amphista…

Amphista doses first patient in AML trial of protein degrader - Pharmafile

Amphista Therapeutics has dosed the first patient in a phase 1 trial of AMX-883, an experimental oral therapy targeting acute myeloid leukaemia (AML) and

pharmafile.com
1
400
First 90 days of antipsychotic treatment linked to rapid metabolic changes pharmafile.com/news/first-90…

First 90 days of antipsychotic treatment linked to rapid metabolic changes - Pharmafile

The first 90 days after starting antipsychotic treatment are a critical period for monitoring blood glucose and weight, according to a study led by University

pharmafile.com
238
Jennings becomes President of Beckman Coulter Diagnostics pharmafile.com/appointments/…

Jennings becomes President of Beckman Coulter Diagnostics - Pharmafile

Beckman Coulter Diagnostics has appointed Catherine Jennings as its new President. 

pharmafile.com
405
Digital platform cuts pharmaceutical quality-record approval times by up to 90% pharmafile.com/news/digital-…

Digital platform cuts pharmaceutical quality-record approval times by up to 90% - Pharmafile

A digital platform for exchanging pharmaceutical quality records between supply-chain partners is now commercially available, following an Innovate UK-funded

pharmafile.com
1
392
Boyds expands Regulatory Affairs team to support growing demand pharmafile.com/appointments/…

Boyds expands Regulatory Affairs team to support growing demand - Pharmafile

Vicki Hayes has joined Boyds as Vice President of Regulatory Affairs with Jan Ohotski becoming Director of Regulatory Affairs.  

pharmafile.com
1
629
Sterling doubles ADC manufacturing capacity at Welsh facility pharmafile.com/news/sterling…

Sterling doubles ADC manufacturing capacity at Welsh facility - Pharmafile

Sterling Pharma Solutions has completed a multi-million-pound expansion of its dedicated bioconjugation facility in Deeside, Wales, doubling manufacturing

pharmafile.com
528
Femtosecond laser cuts lung tumour margin assessment time pharmafile.com/news/femtosec…

Femtosecond laser cuts lung tumour margin assessment time - Pharmafile

Femtosecond laser imaging has reduced the time needed to assess lung tumour margins from 36 minutes to less than six in a recent study, potentially giving

pharmafile.com
510
Blood sensor detects Parkinson’s-associated proteins in 40 minutes pharmafile.com/news/blood-se…

Blood sensor detects Parkinson’s-associated proteins in 40 minutes - Pharmafile

Researchers at King Abdullah University of Science and Technology (KAUST) and the University of Oxford have developed a blood-based electronic sensor capable

pharmafile.com
1
1
1
363
Load more